MLINA Share Price Performance
€3.82
0.00 (0.00%)
Price €3.82
Share Price€3.82
MLINA Community Narratives
There are no narratives available yet.
Recent MLINA News & Updates
No updates
Inmolecule Nanotech, S.A. Key Details
Last Reported Earnings
n/a
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Inmolecule Nanotech, S.A. Competitors
Snowflake Analysis
About MLINA
- Founded
- 1999
- Employees
- n/a
- CEO
- WebsiteView website
Inmolecule Nanotech, S.A., a biotech company, develops active ingredient nano particles for various applications in the home and personal care, agriculture, aquaculture, and pharmaceutical industries. The company provides Nano-Phyto-Chemistry platform that utilizes plant extracts at the nanometric scale to eliminate infectious germs, including viruses, fungi, bacteria, spores, and mycobacteria, and others. Its products include surface sanitizers/disinfectants, and vitamin C and zinc dietary supplements. The company was founded in 1999 and is based in Madrid, Spain.
Market Insight
The number of IPOs and the capital raised this year are on track to outpace the last three years combined. And the thing is, successful IPOs attract more IPOs. Some will be genuine gems, while others, not so much. That’s why this week, we’re digging into the IPO market, and more importantly, how you can improve your odds of spotting a winner.
Continue reading
Spanish Market Performance
- 7 Days: -1.6%
- 3 Months: 2.3%
- 1 Year: 24.4%
- Year to Date: 21.1%
Over the last 7 days, the market has dropped 2.6%, driven by a decline of 5.0% in the Consumer Discretionary sector. In the last year, the market is actually up 23%. As for the next few years, earnings are expected to grow by 4.8% per annum. Market details ›